565 related articles for article (PubMed ID: 17414958)
1. Macrophages and their products in rheumatoid arthritis.
Szekanecz Z; Koch AE
Curr Opin Rheumatol; 2007 May; 19(3):289-95. PubMed ID: 17414958
[TBL] [Abstract][Full Text] [Related]
2. Update on cytokines in rheumatoid arthritis.
Brennan F; Beech J
Curr Opin Rheumatol; 2007 May; 19(3):296-301. PubMed ID: 17414959
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis in rheumatoid arthritis: pathogenic and clinical significance.
Szekanecz Z; Szegedi G; Koch AE
J Investig Med; 1998 Feb; 46(2):27-41. PubMed ID: 9549225
[TBL] [Abstract][Full Text] [Related]
4. [Understanding rheumatoid arthritis].
Sibilia J; Sordet C; Mrabet D; Wachsmann D
Rev Prat; 2005 Dec; 55(19):2134-42. PubMed ID: 16544924
[TBL] [Abstract][Full Text] [Related]
5. Chemokines and chemokine receptors as novel therapeutic targets in rheumatoid arthritis (RA): inhibitory effects of traditional Chinese medicinal components.
Chen X; Oppenheim JJ; Howard OM
Cell Mol Immunol; 2004 Oct; 1(5):336-42. PubMed ID: 16285892
[TBL] [Abstract][Full Text] [Related]
6. Stromal cells and osteoclasts are responsible for exacerbated collagen-induced arthritis in interferon-beta-deficient mice.
Treschow AP; Teige I; Nandakumar KS; Holmdahl R; Issazadeh-Navikas S
Arthritis Rheum; 2005 Dec; 52(12):3739-48. PubMed ID: 16320324
[TBL] [Abstract][Full Text] [Related]
7. Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients.
Iwamoto T; Okamoto H; Toyama Y; Momohara S
FEBS J; 2008 Sep; 275(18):4448-55. PubMed ID: 18662305
[TBL] [Abstract][Full Text] [Related]
8. Bibliography. Current World Literature. Rheumatoid arthritis.
Curr Opin Rheumatol; 2007 May; 19(3):319-31. PubMed ID: 17489150
[No Abstract] [Full Text] [Related]
9. Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis.
Vandooren B; Noordenbos T; Ambarus C; Krausz S; Cantaert T; Yeremenko N; Boumans M; Lutter R; Tak PP; Baeten D
Arthritis Rheum; 2009 Apr; 60(4):966-75. PubMed ID: 19333931
[TBL] [Abstract][Full Text] [Related]
10. Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis.
Andreakos E; Rauchhaus U; Stavropoulos A; Endert G; Wendisch V; Benahmed AS; Giaglis S; Karras J; Lee S; Gaus H; Bennett CF; Williams RO; Sideras P; Panzner S
Arthritis Rheum; 2009 Apr; 60(4):994-1005. PubMed ID: 19333921
[TBL] [Abstract][Full Text] [Related]
11. [Role of chemokines in the pathogenesis of rheumatoid arthritis].
Nanki T
Nihon Rinsho; 2005 Jan; 63 Suppl 1():195-9. PubMed ID: 15799345
[No Abstract] [Full Text] [Related]
12. [Chemokines, a new family of cytokines in inflammatory cell recruitment].
Martínez Martínez CM; Hernández Pando R
Rev Invest Clin; 1999; 51(4):255-68. PubMed ID: 10546507
[TBL] [Abstract][Full Text] [Related]
13. Chemokines and their receptors in rheumatoid arthritis: future targets?
Koch AE
Arthritis Rheum; 2005 Mar; 52(3):710-21. PubMed ID: 15751074
[No Abstract] [Full Text] [Related]
14. Development of an ex vivo cellular model of rheumatoid arthritis: critical role of CD14-positive monocyte/macrophages in the development of pannus tissue.
Nozaki T; Takahashi K; Ishii O; Endo S; Hioki K; Mori T; Kikukawa T; Boumpas DT; Ozaki S; Yamada H
Arthritis Rheum; 2007 Sep; 56(9):2875-85. PubMed ID: 17763413
[TBL] [Abstract][Full Text] [Related]
15. Chemokine and chemokine receptor blockade in arthritis, a prototype of immune-mediated inflammatory diseases.
Szekanecz Z; Koch AE; Tak PP
Neth J Med; 2011 Sep; 69(9):356-66. PubMed ID: 21978977
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of angiogenic pathways in rheumatoid arthritis: potential for therapeutic targeting.
Veale DJ; Fearon U
Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):941-7. PubMed ID: 16980216
[TBL] [Abstract][Full Text] [Related]
17. The role of macrophage migration inhibitory factor in the inflammatory immune response and rheumatoid arthritis.
Santos LL; Morand EF
Wien Med Wochenschr; 2006 Jan; 156(1-2):11-8. PubMed ID: 16465610
[TBL] [Abstract][Full Text] [Related]
18. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells.
González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M
Arthritis Rheum; 2009 Apr; 60(4):1006-19. PubMed ID: 19333946
[TBL] [Abstract][Full Text] [Related]
19. The role of IL-1 and IL-1Ra in joint inflammation and cartilage degradation.
Jacques C; Gosset M; Berenbaum F; Gabay C
Vitam Horm; 2006; 74():371-403. PubMed ID: 17027524
[TBL] [Abstract][Full Text] [Related]
20. Targeting cellular adhesion molecules, chemokines and chemokine receptors in rheumatoid arthritis.
Haringman JJ; Oostendorp RL; Tak PP
Expert Opin Emerg Drugs; 2005 May; 10(2):299-310. PubMed ID: 15934868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]